J&J suspends sales forecast for Covid-19 vaccine Johnson & Johnson has suspended its sales forecast for Covid-19 vaccines due to a global supply surplus and demand uncertainty - and cut its adjusted … Business • 19 Apr
J&J suspends supply of personal care products to Russia Johnson & Johnson has said today it would halt sale of personal care products in Russia, joining other companies that have limited their business in … Business • 29 Mar
€150m Janssen investment to create up to 180 jobs Up to 180 jobs are to be created by the pharmaceutical company Janssen Sciences Ireland in Co Cork. Business • 25 Mar
J&J expects 2022 Covid vaccine sales to jump up to 46% Johnson & Johnson has said it expects to generate as much as $3.5 billion from the sale of its Covid-19 vaccine this year compared to … Business • 25 Jan
Johnson & Johnson plans to split into two companies Johnson & Johnson said today that it is planning to break up into two companies, splitting off its consumer health division that sells Band-Aids and … Business • 12 Nov 21
J&J keeps vaccine sales outlook unchanged Johnson & Johnson has today raised its annual adjusted profit forecast, but stuck to its Covid-19 vaccine sales target of $2.5 billion as it works … Business • 19 Oct 21
J&J forecasts $2.5 billion in Covid vaccine sales Johnson & Johnson has today forecast just $2.5 billion in 2021 sales of its Covid-19 vaccine, which has fallen way behind rival shots from Pfizer … Business • 21 Jul 21
Johnson & Johnson to 'exit' US opioid business US pharmaceutical giant Johnson & Johnson will "exit from the opioid business nationally" as part of a $230 million settlement with New York, the state's … US • 26 Jun 21
EMA: Benefits of J&J Covid-19 vaccine outweigh risks The European Medicines Agency has said the benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks. Coronavirus • 20 Apr 21
J&J reports $100m in vaccine sales in first quarter Johnson & Johnson has today beaten expectations for quarterly revenue and profit and raised dividend payouts to shareholders. Business • 20 Apr 21
Johnson & Johnson delays European vaccine roll-out Johnson & Johnson has said it will delay the roll-out of its Covid-19 vaccine in Europe after US authorities moved to suspend use of the … Coronavirus • 13 Apr 21
EMA to review blood clot link with J&J Covid-19 vaccine The EU's drug regulator has said it has launched a review of possible links between the Johnson & Johnson coronavirus vaccine and blood clots after … Coronavirus • 09 Apr 21
J&J to deliver Covid-19 vaccine to Europe from 19 April Johnson & Johnson has said it would start delivering its single-shot Covid-19 vaccine to Europe on 19 April, giving the continent a boost as it … Coronavirus • 29 Mar 21
One-shot J&J vaccine approved by EU drugs regulator The European Union's drugs regulator has recommended conditionally approving Johnson & Johnson's single dose Covid-19 vaccine. Coronavirus • 11 Mar 21
US to approve Johnson & Johnson Covid vaccine A US panel of independent experts has voted unanimously in favour of recommending Johnson & Johnson's one-dose Covid-19 shot for emergency approval. Coronavirus • 27 Feb 21
Johnson & Johnson promises 2021 profit jump Johnson & Johnson has today forecast 2021 profit above Wall Street estimates and promised data from its widely watched coronavirus vaccine trial soon. Business • 26 Jan 21
Johnson & Johnson pauses Covid vaccine trial Johnson & Johnson has temporarily halted its Covid-19 vaccine trial because one of its participants had become sick, the company said. Coronavirus • 13 Oct 20
J&J in deal for autoimmune disease specialist Moment Johnson & Johnson has today agreed to pay about $6.5 billion in cash to buy Momenta Pharmaceuticals in a deal aimed at expanding its portfolio … Business • 19 Aug 20
Covid vaccine 'likely' to be available in 2021 - Fauci Drug companies will likely have tens of millions of doses of coronavirus vaccines in the early part of next year, with production ramping up to … Coronavirus • 05 Aug 20
Prescription drugs boosts Johnson & Johnson forecasts Johnson & Johnson raised its full-year earnings forecast as it reported higher third-quarter sales of psoriasis treatment Stelara and cancer drug Imbruvica while attempting to … Business • 15 Oct 19
US firm ordered to pay man $8bn over breast growth A Pennsylvania jury has ruled that US pharmaceutical giant Johnson & Johnson must pay $8 billion in damages and interest for failing to warn that … World • 09 Oct 19
Purdue deal to rank among biggest in pharma history OxyContin maker Purdue Pharma LP has reached a tentative multibillion-dollar agreement with some plaintiffs aimed at settling thousands of lawsuits over its alleged role in … Business • 16 Sep 19
J&J boosted by better than expected pharma unit sales Johnson & Johnson beat quarterly profit estimates on higher sales at its pharmaceuticals unit even as it faces fierce competition for some of its biggest … Business • 16 Apr 19
J&J shares drop 6% following report over asbestos Shares of Johnson & Johnson (J&J) fell over 6% after Reuters reported that the pharmaceutical company knew that its baby powder was contaminated with cancer-causing … World • 14 Dec 18
Reversal of J&J $72m verdict over talc cancer risks Johnson & Johnson has won the reversal of a $72m (€61.3m) verdict in the US in favour of the family of a woman whose death … Business • 18 Oct 17
